Crossroads: The role of biomarkers in the management of lumps in the breast
2023-05-02
(Press-News.org)
“A biomarker or set of biomarkers to inform on the individual progression risk would be beneficial to the patient and cost-effective for the healthcare system."
BUFFALO, NY- May 2, 2023 – A new research perspective was published in Oncotarget's Volume 14 on April 24, 2023, entitled, “Crossroads: the role of biomarkers in the management of lumps in the breast.”
Here, Dr. Georg F. Weber from the University of Cincinnati Academic Health Center discusses a long-standing issue in women’s health: lumps in the breast. Women over the age of 40 years often have lumps in their breasts that are not cancerous at the time of biopsy (comprising atypias, hyperplasias, papillomas, radial scars, lobular carcinoma in situ, ductal carcinoma in situ (DCIS)). These premalignant lesions in the breast pose a difficult decision-making problem, whether to treat proactively and accept the side effects or to engage in watchful waiting and possibly encounter a later diagnosis of invasive cancer.
These patients need to make the difficult decision whether to treat the lesions proactively and accept the substantial compromise in their quality of life (from surgery, radiation, or hormone therapy: Surgery often ensues for definitive diagnosis. Radiation may follow the surgical resection of DCIS by lumpectomy. Hormone therapy can come into play as a strategy for risk reduction if the estimated 5-year risk exceeds 1.6% in the Gail model [2]) or to engage in watchful waiting and risk a later diagnosis of invasive cancer (the proverbial sword of Damocles). Currently, two forms of assessment are available to facilitate making that choice.
Decades of cancer diagnosis and treatment have achieved substantial improvements. Yet, with every milestone of progress, new needs have surfaced. Breast care is privileged to have the availability of mammography and biopsy to assess the propensities of lumps.
“A meaningful next step needs to entail biomarker development, pointing the way toward either preemptive treatment or watchful waiting at the crossroad.”
Read the full perspective: DOI: https://doi.org/10.18632/oncotarget.28402
Correspondence to: Georg F. Weber
Email: georg.weber@uc.edu
Keywords: breast cancer premalignant lesion, biomarker, biopsy, mammography
About Oncotarget: Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
To learn more about Oncotarget, visit Oncotarget.com and connect with us on social media:
Twitter
Facebook
YouTube
Instagram
LinkedIn
Pinterest
LabTube
Soundcloud
Click here to subscribe to Oncotarget publication updates.
For media inquiries, please contact: media@impactjournals.com.
Oncotarget Journal Office
6666 East Quaker Str., Suite 1A
Orchard Park, NY 14127
Phone: 1-800-922-0957 (option 2)
###
END
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
2023-05-02
Electroencephalography (EEG) is an indispensable tool used by clinicians to diagnose neurological diseases and by researchers to study and discover brain circuit mechanisms that support sensory, mnemonic, and cognitive processing. A new software - Openseize - created by Dr. Matthew Caudill, an investigator at the Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital and assistant professor at Baylor College of Medicine, can now analyze massive amounts of one-dimensional digital ...
2023-05-02
WASHINGTON, DC – Jefferson Sciences Associates (JSA) has announced the award of $558,060 through its JSA Initiatives Fund Program. The program supports projects by staff and scientific users at the U.S. Department of Energy’s Thomas Jefferson National Accelerator Facility. The FY23 program awards leveraged over $800,000 in matching funds, and taken together, the program and matching awards total over $1.3 million. Project awards include scientific meeting support, education and career development, and outreach activities, ...
2023-05-02
Sophisticated systems for the detection of biomarkers — molecules such as DNA or proteins that indicate the presence of a disease — are crucial for real-time diagnostic and disease-monitoring devices.
Holger Schmidt, distinguished professor of electrical and computer engineering at UC Santa Cruz, and his group have long been focused on developing unique, highly sensitive devices called optofluidic chips to detect biomarkers.
Schmidt’s graduate student Vahid Ganjalizadeh led an effort to use machine learning to enhance ...
2023-05-02
The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, “How the Brain's Dopamine Circuitry Helps Regulate Cognitive Flexibility and Reward-Seeking” on Tuesday, May 9, 2023, at 2:00 pm EST. The presenter will be Nikhil Urs, Ph.D., Assistant Professor of Pharmacology and Therapeutics at the University of Florida and a recipient of a 2018 BBRF Young Investigator Grant. The webinar will be hosted by Jeffrey Borenstein, M.D., President & CEO of the Brain & Behavior Research Foundation, and host of the public television series Healthy Minds.
Register today at BBRFoundation.org
Dopamine ...
2023-05-02
Artificial intelligence (AI) technology in the medical field has the possibility to automate diagnoses, decrease physician workload, and even to bring specialized healthcare to people in rural areas or developing countries. However, with possibility comes potential pitfalls.
Analyzing crowd-sourced sets of data used to create AI algorithms from medical images, University of Maryland School of Medicine (UMSOM) researchers found that most did not include patient demographics. In the study published April 3 in Nature Medicine, the researchers also found that the algorithms did not evaluate for inherent biases either. That means they have ...
2023-05-02
AMES, IA — Iowa State researchers in psychology and engineering found women experience cybersickness with virtual reality headsets more often than men. Their ongoing work, supported by a new $600,000 grant from the National Science Foundation, explores why this difference exists and options to help individuals adapt.
Psychology professor Jonathan Kelly studies human computer interaction, spatial cognition and virtual reality. He says gender discrepancies in cybersickness may not seem that important when it’s related to video games and other forms of entertainment.
"But it’s still a problem, and when VR gets to the point ...
2023-05-02
Using blood samples to study diseases that originate in the brain is a difficulty faced by psychiatric genetics in the search for markers of mental health disorders. Researchers at the Federal University of São Paulo (UNIFESP) in Brazil have shown that this hindrance can be surmounted by analyzing microRNAs in extracellular vesicles (EVs), which are produced by most cells in the body, including neurons and other nervous system cells.
The study was supported by FAPESP and is reported ...
2023-05-02
Three years ago, an international study commissioned by the journal Lancet listed 12 modifiable factors that increased the risk of dementia, including three new ones: excessive alcohol, head injury and air pollution.
Writing in the May 2, 2023 issue of the Journal of Alzheimer’s Disease, a team of researchers, led by scientists at University of California San Diego, further elaborate on how exposure to the last of those new factors — ambient air pollution, such as car exhaust and power plant emissions — is associated with a measurably greater risk of developing dementia over time.
Senior author William S. Kremen, PhD, professor ...
2023-05-02
GRAND RAPIDS, Mich. (May 2, 2023) — Van Andel Institute scientists have developed a new extraction protocol for RNA-seq and metabolomic analysis, offering a more complete picture of cellular activity than either technique on its own.
The protocol employs a streamlined extraction from a single sample, which reduces variation, improves efficiency, preserves data fidelity and maximizes use of precious biospecimens.
“Our new technique enables researchers to study metabolic phenotypes in a unique way while getting the most information we can out of single samples,” ...
2023-05-02
Scientists at UMass Chan Medical School have developed a technology to deliver gene therapy directly to lung tissue through intranasal administration, a development that could potentially create a new class of treatments for lung disease.
Published in The Proceedings of the National Academy of Sciences, the study by a multidisciplinary team of RNA biologists, chemical biologists, immunologists and virologists describes the delivery of siRNA molecules locally to lung tissue. It is the first demonstration that multimeric ...
LAST 30 PRESS RELEASES:
[Press-News.org] Crossroads: The role of biomarkers in the management of lumps in the breast
